Azenta Inc (AZTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Azenta Inc (AZTA) has a cash flow conversion efficiency ratio of 0.002x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.77 Million) by net assets ($1.51 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Azenta Inc market cap and net worth for the company's overall valuation and market capitalisation.
Azenta Inc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Azenta Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Azenta Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Azenta Inc ranked by their cash flow conversion efficiency. Explore Azenta Inc cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
uniQure N.V
F:UQ1
|
-0.256x |
|
Yulon Finance Corp
TW:9941
|
0.082x |
|
KSB Ltd
NSE:KSB
|
0.019x |
|
Paramount Group Inc
NYSE:PGRE
|
0.001x |
|
PSMC CO. Ltd
KQ:024850
|
-0.032x |
|
Sylvamo Corp
NYSE:SLVM
|
-0.010x |
|
Adient PLC
NYSE:ADNT
|
0.099x |
|
Kyland Technology Co Ltd
SHE:300353
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Azenta Inc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Azenta Inc from 1994 to 2025. View AZTA stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $1.73 Billion | $72.18 Million | 0.042x | +48.47% |
| 2024-09-30 | $1.77 Billion | $49.74 Million | 0.028x | +1121.63% |
| 2023-09-30 | $2.53 Billion | $5.83 Million | 0.002x | +101.66% |
| 2022-09-30 | $3.36 Billion | $-466.05 Million | -0.139x | -222.55% |
| 2021-09-30 | $1.33 Billion | $149.86 Million | 0.113x | +262.40% |
| 2020-09-30 | $1.21 Billion | $37.87 Million | 0.031x | -60.89% |
| 2019-09-30 | $1.14 Billion | $90.90 Million | 0.080x | -22.57% |
| 2018-09-30 | $717.83 Million | $73.96 Million | 0.103x | -34.93% |
| 2017-09-30 | $607.64 Million | $96.22 Million | 0.158x | +121.71% |
| 2016-09-30 | $553.69 Million | $39.55 Million | 0.071x | +3.24% |
| 2015-09-30 | $632.04 Million | $43.73 Million | 0.069x | -17.30% |
| 2014-09-30 | $642.89 Million | $53.78 Million | 0.084x | -2.69% |
| 2013-09-30 | $632.66 Million | $54.39 Million | 0.086x | +54.89% |
| 2012-09-30 | $649.30 Million | $36.04 Million | 0.056x | -67.16% |
| 2011-09-30 | $518.60 Million | $87.65 Million | 0.169x | +136.10% |
| 2010-09-30 | $389.35 Million | $27.87 Million | 0.072x | +140.50% |
| 2009-09-30 | $319.62 Million | $-56.49 Million | -0.177x | -802.04% |
| 2008-09-30 | $542.40 Million | $13.66 Million | 0.025x | -70.28% |
| 2007-09-30 | $860.24 Million | $72.87 Million | 0.085x | +3.89% |
| 2006-09-30 | $799.53 Million | $65.19 Million | 0.082x | -18.53% |
| 2005-09-30 | $310.89 Million | $31.11 Million | 0.100x | +254.67% |
| 2004-09-30 | $313.81 Million | $8.86 Million | 0.028x | +109.52% |
| 2003-09-30 | $162.99 Million | $-48.33 Million | -0.297x | -64.47% |
| 2002-09-30 | $308.73 Million | $-55.66 Million | -0.180x | -470.36% |
| 2001-09-30 | $424.93 Million | $20.68 Million | 0.049x | +253.31% |
| 2000-09-30 | $415.04 Million | $-13.18 Million | -0.032x | -182.90% |
| 1999-09-30 | $143.60 Million | $5.50 Million | 0.038x | +159.17% |
| 1998-09-30 | $121.80 Million | $1.80 Million | 0.015x | +199.16% |
| 1997-09-30 | $134.20 Million | $-2.00 Million | -0.015x | +64.02% |
| 1996-09-30 | $50.70 Million | $-2.10 Million | -0.041x | +76.53% |
| 1995-09-30 | $40.80 Million | $-7.20 Million | -0.176x | -164.71% |
| 1994-09-30 | $4.50 Million | $-300.00K | -0.067x | -- |
About Azenta Inc
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, in… Read more